Fig. 1. Summary of the applied strategies for identification of novel gene–disease associations.
a Patient-centered approach to systematically interrogate variants in genes not yet associated to human diseases in patients with no genetic diagnosis after exome/genome sequencing (ES/GS). b Gene variant centered approach to analyze de novo variants in cases with ES/GS performed and no genetic diagnosis. DP depth of reads, pLI probability of loss-of-function intolerance.